1
Return

First-Trimester Molecular Screening for Fetal and Neonatal Alloimmune Thrombocytopenia: Early Identification of At-Risk Pregnancies

delete2026-06-21
delete0
PRE
AI
S
Sebastián Blanco *
L
Luis Horacio Carrizo
J
José María Lazarte
L
Laura Carina Vega
J
Jorge Mario Culaso
S
Sandra Verónica Gallego
DOI：10.1002/pd.70203delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The aim of this study was to evaluate the feasibility and clinical value of implementing first-trimester molecular HPA screening to identify pregnancies at risk for FNAIT.

Journal

Prenatal Diagnosis cover
Prenatal Diagnosis
IF:
2.7
Papers:
425
Citations:
6.8K

Organization

F
fundacion banco central de sangre
Scholars:
6
Papers: 1
Citations: 0
M
Ministerio de Salud
Scholars:
18
Papers: 10
Citations: 21
Cited Papers

Cited Papers

Citing Papers

Citing Papers